Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease
AssigneeThe Regents of the University of Colorado
InventorsRichard J. JOHNSON, Miguel A. LANASPA-GARCIA, Sondra BLAND
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of one or more fructokinase (ketohexokinase) (KHK) inhibitors to both prevent and treat a wide variety of diseases including, but not limited to, alcohol craving, alcohol addiction, alcohol induced liver disease including fatty liver and cirrhosis.
Claims25
A method of reducing a craving for alcohol in a subject, comprising:
- administering a therapeutically effective amount of a ketohexokinase (KHK) inhibitor to the subject to inhibit KHK activity in the subject.
A method of treating an alcoholism in a subject in need thereof, comprising:
- administering to the subject a therapeutically effective amount of a ketohexokinase (KHK) inhibitor.
A method of treating an alcohol-induced liver disease in a subject, comprising:
- administering to the subject a composition comprising a therapeutically effective amount of a KHK inhibitor.
A method of treating alcohol-induced pancreatitis in a subject, the method comprising:
- administering a therapeutically effective amount of a ketohexokinase (KHK) inhibitor to the subject to inhibit KHK activity in the subject.
A method of preventing alcoholism, an alcohol-induced liver disease, or alcohol-induced pancreatitis in a subject or recurrence of the same, the method comprising:
- administering a therapeutically effective amount of a ketohexokinase (KHK) inhibitor to the subject to inhibit KHK activity in the subject.
Dependencies are inferred from the claim text.